Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Ibuprofen and Pseudoephedrine 200 mg/30 mg Tablets
NCT03429738Phase 1Completed
- Sponsor
- Institut für Pharmakologie und Präventive Medizin
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen and pseudoephedrine in pain, fever, common cold and 2 more (2 arms), sponsored by Institut für Pharmakologie und Präventive Medizin. Primary endpoints: Area Under the Curve from time 0 to the last measurable concentration at 7 days and Maximum Serum Concentration at 7 days. Started Apr 2014; status: completed.
02
Drugs
ibuprofenpseudoephedrine
03
Conditions
painfevercommon coldback painHeadache
Beyond the preview
Go deeper on NCT03429738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429738.